Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2018-A00541-54 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Laboratoire de Physique ENS de Lyon | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Intensive care unit acquired muscle weakness (ICUAW), is a common disease which influence rehabilitation, extend mechanical ventilation and length of stay in intensive care unit, and affect quality of life at hospital discharge.
To prevent ICUAW, different strategies of early mobilization are recommended. But all cannot be applied in all ICU patients. Some of them benefit from heavy therapies like circulatory assistance or renal replacement therapy for example, that limit mobilization.
Cycloergometer is a tool that allows continuous passive mobilization in bedridden and even unconscious patients.
Neuromuscular electrical stimulation (NMES) is an alternative that helps preserve muscle mass and limit muscle atrophy.
Early bedside cycle exercise coupled with NMES is an interesting new approach where application of an electrical stimulation along specific motor nerves on each lower limb, generates muscles contractions and pedaling on cycloergometer.
The aim of this study is to evaluate safety and feasibility of this coupled technique called Functional Electrical Stimulation (FES) Cycling, in ICU patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental | Experimental | Patients with FES Cycling |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FES cycling | Device | On the patient, three pairs of electrodes will be applied on tibial hamstring, quadriceps and gluteal muscles of each lower limb. Cycloergometer will be installed in passive mode. Then, optimal stimulation intensity for each muscle will be defined. During twenty minutes, neuromuscular electrical stimulation will generate a passive pedaling on cycloergometer. |
| Measure | Description | Time Frame |
|---|---|---|
| Tolerance | Number of FES Cycling sessions that must be stopped because of the presence of at least 1 following criteria (these criteria are qualitative (presence or absence) and therefore do not add up):
| During the FES Cycling session (day 1) |
| Measure | Description | Time Frame |
|---|---|---|
| Systolic blood pressure | Haemodynamic repercussions of a FES Cycling session measured by Systolic blood pressure | During the FES Cycling session (day 1) |
| Haemodynamic tolerance Heart rate | Haemodynamic repercussions of a FES Cycling session measured by Heart rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jérôme MOREL, MD | Centre Hospitalier Universitaire de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Saint-Etienne | Saint-Etienne | 42055 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018908 | Muscle Weakness |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| During the FES Cycling session (day 1) |
| Cardiac output measured | Haemodynamic repercussions of a FES Cycling session measured by Cardiac output measured in transthoracic echocardiography | During the FES Cycling session (day 1) |
| Fick equation | Haemodynamic repercussions of a FES Cycling session measured by oxygen consumption according to the Fick equation (cardiac output x (arterial content in O2 - venous content in O2)) | During the FES Cycling session (day 1) |
| Arterial lactates | Haemodynamic repercussions of a FES Cycling session measured Arterial lactates | During the FES Cycling session (day 1) |
| Venous oxygen | Haemodynamic repercussions of a FES Cycling session measured by Venous oxygen saturation | During the FES Cycling session (day 1) |
| Amine dosage | Haemodynamic repercussions of a FES Cycling session measured by Amine dosage | During the FES Cycling session (day 1) |
| Respiratory tolerance Oxygen saturation | Respiratory repercussions of a FES Cycling session measured by Oxygen saturation | During the FES Cycling session (day 1) |
| Respiratory tolerance | Respiratory repercussions of a FES Cycling session measured by Respiratory rate | During the FES Cycling session (day 1) |
| Respiratory rate | Respiratory repercussions of a FES Cycling session measured by PaCO2 and PaO2 | During the FES Cycling session (day 1) |
| Diastolic cerebral artery | Neurological repercussions of a FES Cycling session measured by diastolic average cerebral artery measured by transcranial Doppler | During the FES Cycling session (day 1) |
| Pulsatility index | Neurological repercussions of a FES Cycling session measured by Average of pulsatility index, measured by transcranial Doppler. | During the FES Cycling session (day 1) |
| Intracranial pression | Neurological repercussions of a FES Cycling session measured by, If sensors present, Intracranial pression. | During the FES Cycling session (day 1) |
| Cerebral perfusion pressure | Neurological repercussions of a FES Cycling session measured by, If sensors present, Cerebral perfusion pressure. | During the FES Cycling session (day 1) |
| Cerebral tissue oxygen pressure | Neurological repercussions of a FES Cycling session measured by, If sensors present, Cerebral tissue oxygen pressure. | During the FES Cycling session (day 1) |
| FES cycling installation | FES Cycling technical feasibility measured by installation and uninstallation times Cycloergometer, | After the FES Cycling session (day 1) |
| FES Cycling technical feasibility | FES Cycling technical feasibility measured by number of persons needed. | After the FES Cycling session (day 1) |
| Duration of FES Cycling session | FES Cycling technical feasibility measured by total duration of FES Cycling session. | After the FES Cycling session (day 1) |
| Failure FES Cycling session | FES Cycling technical feasibility measured by number of procedural failures. | After the FES Cycling session (day 1) |
| D009422 | Nervous System Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |